Guangzhou Baiyunshan is First-to-China-Market with Generic Viagra

Guangzhou Baiyunshan Pharma was granted CFDA approval to market the first generic version of Viagra in China. Viagra (sildenafil citrate) is Pfizer's blockbuster treatment for erectile dysfunction. China's ED market -- comprised of Viagra, its western competitors and now Baiyunshan -- is estimated at almost $300 million a year. Baiyunshan will price its generic Viagra at about half the $15 that Pfizer charges for single Viagra pill in China. More details... Stock Symbols: (SHA: 600332; HK: 0874)   (NYSE: PFE) Share this with colleagues: // //